Cargando…

Blepharospasm Patients after Botulinum Toxin – Sleep Approach

Background Blepharospasm is a focal dystonia that affects the orbicularis oculi muscles. The interest in nonmotor symptoms is due to their impact on quality of life. Objective We evaluated the frequency of sleep disorders and circadian rhythm in a sample of Brazilian blepharospasm patients. Method...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lestingi, Silvia, Kim, Lenise, Gonçalves, Bruno da Silva Brandão, Silva, Sonia Maria Azevedo, Ferraz, Henrique, Coelho, Fernando Morgadinho, Borges, Vanderci
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Revinter Publicações Ltda. 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157829/ https://www.ncbi.nlm.nih.gov/pubmed/37151762 http://dx.doi.org/10.1055/s-0043-1767753

Ejemplares similares

Botulinum Toxin Therapy in Congenital Blepharospasm
por: Wabbels, Bettina
Publicado: (2014)

Injecting botulinum toxin into the treatment of blepharospasm
por: Popescu, Marius Nicolae, et al.
Publicado: (2018)

Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins
por: Hassell, Travis J.W., et al.
Publicado: (2020)

Botulinum toxin injections for blepharospasm prior to ocular surgeries
por: Okumus, Seydi, et al.
Publicado: (2012)

Botulinum a toxin treatment of hemifacial spasm and blepharospasm.
por: Park, Y. C., et al.
Publicado: (1993)

Specific characteristics of the medical history of swallowing before and after application of botulinum toxin in patients with cervical dystonia
por: Vilanova, Tatiana Fonseca Del Debbio, et al.
Publicado: (2019)

Difficulties with differentiating botulinum toxin treatment effects in essential blepharospasm
por: Wabbels, Bettina, et al.
Publicado: (2011)

THE EFFECT OF BOTULINUM TOXIN TYPE A IN PATIENTS WITH ESSENTIAL BLEPHAROSPASM
por: Gaćina, Klara, et al.
Publicado: (2022)

Efficacy of botulinum toxin in benign essential Blepharospasm: Desirable & undesirable effects
por: Anwar, M Shakaib, et al.
Publicado: (2013)

Botulinum toxin relieves anxiety and depression in patients with hemifacial spasm and blepharospasm
por: Dong, Hongjuan, et al.
Publicado: (2018)

Postural stability in blepharospasm: the effects of dual-tasking and botulinum toxin therapy
por: Balal, Mehmet, et al.
Publicado: (2023)

Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm – A Randomized Pilot Study
por: Silkiss, Rona Z., et al.
Publicado: (2023)

The Changes in Corneal Astigmatism after Botulinum Toxin-A Injection in Patients with Blepharospasm
por: Moon, Nam Ju, et al.
Publicado: (2006)

Treatment satisfaction with botulinum toxin: a comparison between blepharospasm and cervical dystonia
por: Leplow, Bernd, et al.
Publicado: (2017)

Comparable Botulinum Toxin Outcomes between Primary and Secondary Blepharospasm: A Retrospective Analysis
por: Martinez-Ramirez, Daniel, et al.
Publicado: (2014)

Preseptal and Pretarsal Botulinum Toxin Injection in Hemifacial Spasm and Blepharospasm: A 10-Year Comparative Study
por: Teekaput, Chutithep, et al.
Publicado: (2023)

Oxymetazoline hydrochloride ophthalmic solution, 0.1%, boosts the effects of botulinum toxin on blepharospasm: a case series
por: Sung, Jonathan, et al.
Publicado: (2022)

Therapeutic Approach to Botulinum Injections for Hemifacial Spasm, Synkinesis and Blepharospasm
por: Yahalom, Gilad, et al.
Publicado: (2022)

What can be expected to be seen in a Neurology ward? Eleven-year experience in a Brazilian university hospital
por: MOREIRA, Daniel Gabay, et al.
Publicado: (2021)

Effects of the periocular botulinum toxin on the ocular surface and anterior chamber: a prospective study in patients with hemifacial spasm and blepharospasm
por: Romero-Caballero, María Dolores, et al.
Publicado: (2023)

Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential Blepharospasm
por: Lee, Seunghyun, et al.
Publicado: (2018)

Outcomes of a regional variant of botulinum toxin type A in the treatment of essential blepharospasm and hemifacial spasms: A retrospective study
por: Maneksha, V, et al.
Publicado: (2021)

Fluid Redistribution in Sleep Apnea: Therapeutic Implications in Edematous States
por: da Silva, Bruno Caldin, et al.
Publicado: (2018)

Blink index as a response predictor of blepharospasm to botulinum neurotoxin‐A treatment
por: Jang, Jeongkyeong, et al.
Publicado: (2021)

Efficacy of Repetitive Transcranial Magnetic Stimulation Combined with Botulinum Toxin Type A for Benign Essential Blepharospasm Patients Accompanied by Anxiety and Depression
por: Yin, Bo, et al.
Publicado: (2021)

Subjective assessment of effectiveness, quality of life, and psychological status of patients receiving botulinum toxin therapy for hemifacial spasm, blepharospasm, or cervical dystonia
por: Kako, Tetsuharu, et al.
Publicado: (2021)

Blepharospasm
Publicado: (1892)

Grey Matter Microstructural Integrity Alterations in Blepharospasm Are Partially Reversed by Botulinum Neurotoxin Therapy
por: Alexandru, Hanganu, et al.
Publicado: (2016)

Average annual cost of Parkinson’s disease in São Paulo, Brazil, with a focus on disease-related motor symptoms
por: Bovolenta, Tânia M, et al.
Publicado: (2017)

Systematic Review and Critical Analysis of Cost Studies Associated with Parkinson's Disease
por: Bovolenta, Tânia M., et al.
Publicado: (2017)

Clinical Outcomes of Individualized Botulinum Neurotoxin Type A Injection Techniques in Patients with Essential Blepharospasm
por: Sung, Youngje, et al.
Publicado: (2015)

Correction: Grey Matter Microstructural Integrity Alterations in Blepharospasm Are Partially Reversed by Botulinum Neurotoxin Therapy
por: Hanganu, Alexandru, et al.
Publicado: (2017)

Comparison of Two Botulinum Neurotoxin A Injection Patterns with or without the Medial Lower Eyelid in the Treatment of Blepharospasm
por: Yang, Hui, et al.
Publicado: (2016)

Increase lipid tear thickness after botulinum neurotoxin A injection in patients with blepharospasm and hemifacial spasm
por: Ho, Ren-Wen, et al.
Publicado: (2018)

Frequency of Hemorrhagic Side Effects of Botulinum Neurotoxin Treatment in Patients with Blepharospasm and Hemifacial Spasm on Antithrombotic Medication
por: Wenninger, Fiona Carolin, et al.
Publicado: (2022)

Use of botulinum toxin for movement disorders
por: Camargo, Carlos Henrique Ferreira, et al.
Publicado: (2019)

Botulinum Toxin in Neurogenic Detrusor Overactivity
por: D'Ancona, Carlos Arturo Levi, et al.
Publicado: (2012)

BOTULINUM TOXIN
por: Nigam, P K, et al.
Publicado: (2010)

Brief considerations on the dispensation profile of the botulinum toxin type A by the Brazilian Unified Health System for treatment of dystonias: Datasus data
por: Chien, Hsin Fen, et al.
Publicado: (2016)

Sleep disorders in Down syndrome: a systematic review
por: Santos, Ravenna Araújo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vugtn26gpi3no2gmmpqfl90q29